Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rose Hill
Atlanta, Georgia, United Statesrosehillacquisition.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Rose Hill Acquisition Corporation was a special purpose acquisition company (SPAC) formed for the purpose of effecting a merger, share exchange, asset acquisition, or similar business combination with one or more businesses. While the company maintained a broad mandate, it specifically targeted high-growth companies in Latin America, with a particular interest in the healthcare and technology sectors. In 2023, the company entered into a definitive business combination agreement with Invo Bioscience, a healthcare services company focused on expanding access to advanced fertility treatment. However, the SPAC ultimately faced liquidation after failing to complete a business combination within its required timeframe.
- Industry
- Investors
02
Partnerships
Invo Bioscience
Beyond the preview
Go deeper on Rose Hill.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Rose Hill.